Form 4 holding
Cheif Financial Officer
Inhibikase Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 48,091
- Estimated value
- $38,473
- Report date
- 01 Mar 2023
- Price
- $0.8000
- Ownership
- Direct
Joseph Frattaroli - Cheif Financial Officer at Inhibikase Therapeutics, Inc.
Issuer-level insider activity
- Role
- Cheif Financial Officer
- Issuer ticker
- IKT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Joseph Frattaroli since 05 Sep 2025
Reported holdings for Joseph Frattaroli in Inhibikase Therapeutics, Inc.
Form 4 holding
Cheif Financial Officer
Inhibikase Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 90,000
- Estimated value
- Report date
- 01 Mar 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Joseph Frattaroli in Inhibikase Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.